Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Genome Wide Association Study Reveals Genetic Predisposition for Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma By Variation in the PREP1-Cbs Locus

Florence Magrangeas, Rowan Kuiper, BSc, Hervé Avet-loiseau, MD PhD, Wilfried Gouraud, Catherine Guérin, Henri Der Sakissian, Jérôme Suhard, Michel Attal, Pieter Sonneveld, MDPhD, Charles Dumontet, MD PhD, Philippe Moreau, Mark van Duin, PhD, Loic Campion, MD, Stephane Minvielle

Blood (2014) 124 (21): 2057.

https://doi.org/10.1182/blood.V124.21.2057.2057

Published: 2014

Journal Articles

Low Level Of NF-Kb Activity Is Associated With Higher Response Rate To Bortezomib-Based Induction Therapy In Patients With Newly Diagnosed Multiple Myeloma

Florence Magrangeas, PhD, Philippe Moreau, MD, Loic Campion, MD, Herve Avet-Loiseau, MD, Catherine Guérin, Wilfried Gouraud, Gérald Marit, MD, Michel Attal, MD, Denis Caillot, MD, Thierry Facon, MD, Cyrille Hulin, MD, Lotfi Benboubker, MD, Brigitte Pegourie, MD, Stephane Minvielle, PhD

Blood (2013) 122 (21): 3106.

https://doi.org/10.1182/blood.V122.21.3106.3106

Published: 2013

Journal Articles

High Resolution Genome-Wide Analyses Revealed That Bortezomib Selects a Prediagnosis Clone In Relapsed Patients with Multiple Myeloma

Florence Magrangeas, Hervé Avet-Loiseau, Olivier Decaux, Wilfried Gouraud, jean Luc Harousseau, Kenneth C. Anderson, Philippe Moreau, MD, Nikhil C. Munshi, MD, Stephane Minvielle

Blood (2010) 116 (21): 2960.

https://doi.org/10.1182/blood.V116.21.2960.2960

Published: 2010

Journal Articles

A High Density Polymorphism Analysis of Factors Correlated with Neurotoxicity to Bortezomib in Patients with Multiple Myeloma.

Stephane Minvielle, Ph.D, Céline Keime, Florence Magrangeas, Julie Vendrell, Wilfried Gouraud, Sergio Rodrigues de Morais, Stephanie Montesinos, Charles Dumontet, H. Avet-Loiseau

Blood (2009) 114 (22): 4816.

https://doi.org/10.1182/blood.V114.22.4816.4816

Published: 2009

Journal Articles

In Myeloma, the Prognostic Impact of Hyperdiploidy Is Mainly Related to the Gain of Chromosome 5

Herve Avet Loiseau, MD, PhD, Cheng Li, Florence Magrangeas, Catherine Guerin, Wilfried Gouraud, Jean-Luc Harousseau, Michel Attal, MD, Gerald Marit, Claire Mathiot, Thierry Facon, Philippe Moreau, Kenneth C Anderson, MD, Loic Campion, MD, Nikhil C. Munshi, MD, Stephane Minvielle

Blood (2008) 112 (11): 632.

https://doi.org/10.1182/blood.V112.11.632.632

Published: 2008

Journal Articles

High-Resolution Genomic Profiles Identify Novel Genes and/or Chromosomal Regions with Prognostic and Oncogenic Significance in Myeloma Patients.

Herve Avet Loiseau, MD, PhD, Nikhil C. Munshi, MD, Cheng Li, Florence Magrangeas, PhD, Wilfried Gouraud, PhD, Catherine Charbonnel, PhD, Jean-Luc Harousseau, MD, Michel Attal, MD, PRD, Gerald Marit, MD, Claire Mathiot, MD, Thierry Facon, MD, Philippe Moreau, MD, Kenneth C. Anderson, MD, Stephane Minvielle, PhD

Blood (2007) 110 (11): 657.

https://doi.org/10.1182/blood.V110.11.657.657

Published: 2007

Journal Articles

Molecular Prognosis in Multiple Myeloma: The IFM Experience.

Olivier Decaux, MD, Florence Magrangeas, PhD, Laurence Lode, PharmD, Catherine Charbonnel, Wilfried Gouraud, Philippe Moreau, MD, Jean-Luc Harousseau, MD, Michel Attal, MD, Regis Bataille, MD, PhD, Loic Campion, MD, Herve Avet Loiseau, MD, PhD, Stephane Minvielle, PhD

Blood (2006) 108 (11): 3491.

https://doi.org/10.1182/blood.V108.11.3491.3491

Published: 2006

Journal Articles

Gene Expression Profiling Comparison between the Major Mature B-Cell Neoplasms and Their Normal Cellular and Anatomic Counterparts: Identification of Candidate Genes Potentially Involved in Lymphomagenesis.

Nicolas Blin, MD, Celine Bossard, MD, Jean-Luc Harousseau, MD, Catherine Charbonnel, Wilfried Gouraud, Loic Campion, MD, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Herve Avet Loiseau, MD,PhD

Blood (2006) 108 (11): 2375.

https://doi.org/10.1182/blood.V108.11.2375.2375

Published: 2006

NARROW

A Genome Wide Association Study Reveals Genetic Predisposition for Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma By Variation in the PREP1-Cbs Locus

Low Level Of NF-Kb Activity Is Associated With Higher Response Rate To Bortezomib-Based Induction Therapy In Patients With Newly Diagnosed Multiple Myeloma

High Resolution Genome-Wide Analyses Revealed That Bortezomib Selects a Prediagnosis Clone In Relapsed Patients with Multiple Myeloma

A High Density Polymorphism Analysis of Factors Correlated with Neurotoxicity to Bortezomib in Patients with Multiple Myeloma.

In Myeloma, the Prognostic Impact of Hyperdiploidy Is Mainly Related to the Gain of Chromosome 5

High-Resolution Genomic Profiles Identify Novel Genes and/or Chromosomal Regions with Prognostic and Oncogenic Significance in Myeloma Patients.

Molecular Prognosis in Multiple Myeloma: The IFM Experience.

Gene Expression Profiling Comparison between the Major Mature B-Cell Neoplasms and Their Normal Cellular and Anatomic Counterparts: Identification of Candidate Genes Potentially Involved in Lymphomagenesis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only